Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1981 Dec;78(12):7584–7588. doi: 10.1073/pnas.78.12.7584

Rapid glucocorticoid inhibition of vasoactive intestinal peptide-induced cyclic AMP accumulation and prolactin release in rat pituitary cells in culture.

W H Rotsztejn, M Dussaillant, F Nobou, G Rosselin
PMCID: PMC349313  PMID: 6278481

Abstract

Vasoactive intestinal peptide (VIP) stimulates both adenosine 3',5'-cyclic monophosphate (cAMP) accumulation and prolactin release in normal rat pituitary cells in culture. cAMP accumulation is significant (P less than 0.01) at VIP concentrations as low as 1 nM and reaches a maximum with 0.1 microM. Addition of dexamethasone as early as 15 min before VIP inhibits VIP stimulation of both cAMP production and PRL secretion. The rapid inhibition is dose-dependent: it appears at doses as low as 0.01 pM and is complete at 1 pM dexamethasone. Increasing concentrations of dexamethasone induce a noncompetitive type of inhibition, as shown by the decrease in Vmax with no change in the apparent Km for VIP. Cycloheximide (1 mM) counteracts the inhibitory effect of dexamethasone on VIP-induced cAMP production, which suggests the involvement of a rapid protein synthesis mechanism. Ru-26988, a specific glucocorticoid devoid of any mineralocorticoid activity and which does not bind to intracellular transcortin-like component, also produces an inhibition of VIP-induced cAMP accumulation. Corticosterone also inhibits VIP-induced cAMP production but at concentrations higher than those of dexamethasone. In contrast, aldosterone, progesterone, estradiol, and testosterone have no effect. These results demonstrate that, in normal rat pituitary cells in culture, glucocorticoids at physiological concentrations rapidly inhibit the cAMP production and prolactin release induced by VIP by acting through specific glucocorticoid receptors.

Full text

PDF
7584

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bataille D., Talbot J. N., Milhaud G., Mutt V., Rosselin G. Effet du peptide intestinal vasoactif (VIP) sur la sécrétion de prolactine chez l'homme. C R Seances Acad Sci III. 1981 Feb 16;292(7):511–513. [PubMed] [Google Scholar]
  2. Borghi C., Nicosia S., Giachetti A., Said S. I. Adenylate cyclase of rat pituitary gland: stimulation by vasoactive intestinal polypeptide (VIP). FEBS Lett. 1979 Dec 15;108(2):403–406. doi: 10.1016/0014-5793(79)80573-6. [DOI] [PubMed] [Google Scholar]
  3. Broer Y., Lhiaubet-Grapin A. M., Rosselin G. Dosage radio-immunologique de l'AMP-3',5'-cyclique. Préparation, purification et contrôle du tyrosine-succinyl-AMPc et de son dérivé iodé. C R Acad Sci Hebd Seances Acad Sci D. 1972 Aug 16;275(7):883–886. [PubMed] [Google Scholar]
  4. Copinschi G., L'Hermite M., Leclercq R., Golstein J., Vanhaelst L., Virasoro E., Robyn C. Effects of glucocorticoids on pituitary hormonal responses to hypoglycemia. Inhibition of prolactin release. J Clin Endocrinol Metab. 1975 Mar;40(3):442–449. doi: 10.1210/jcem-40-3-442. [DOI] [PubMed] [Google Scholar]
  5. Dausse J. P., Duval D., Meyer P., Gaignault J. C., Marchandeau C., Raynaud J. P. The relationship between glucocorticoid structure and effects upon thymocytes. Mol Pharmacol. 1977 Sep;13(5):948–955. [PubMed] [Google Scholar]
  6. De Kloet E. R., McEwen B. S. A putative glucocorticoid receptor and a transcortin-like macromolecule in pituitary cytosol. Biochim Biophys Acta. 1976 Jan 14;421(1):115–123. doi: 10.1016/0304-4165(76)90175-6. [DOI] [PubMed] [Google Scholar]
  7. De Kloet R., Wallach G., McEwen B. S. Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology. 1975 Mar;96(3):598–609. doi: 10.1210/endo-96-3-598. [DOI] [PubMed] [Google Scholar]
  8. Drouin J., Lagacé L., Labrie F. Estradiol-induced increase of the LH responsive to LH releasing hormone (LHRH) in rat anterior pituitary cells in culture. Endocrinology. 1976 Dec;99(6):1477–1481. doi: 10.1210/endo-99-6-1477. [DOI] [PubMed] [Google Scholar]
  9. Dufy B., Vincent J. D., Fleury H., Du Pasquier P., Gourdji D., Tixier-Vidal A. Membrane effects of thyrotropin-releasing hormone and estrogen shown by intracellular recording from pituitary cells. Science. 1979 May 4;204(4392):509–511. doi: 10.1126/science.107590. [DOI] [PubMed] [Google Scholar]
  10. Enjalbert A., Arancibia S., Ruberg M., Priam M., Bluet-Pajot M. T., Rotsztejn W. H., Kordon C. Stimulation of in vitro prolactin release by vasoactive intestinal peptide. Neuroendocrinology. 1980 Sep;31(3):200–204. doi: 10.1159/000123074. [DOI] [PubMed] [Google Scholar]
  11. Euker J. S., Meites J., Riegle G. D. Effects of acute stress on serum LH and prolactin in intact, castrate and dexamethasone-treated male rats. Endocrinology. 1975 Jan;96(1):85–92. doi: 10.1210/endo-96-1-85. [DOI] [PubMed] [Google Scholar]
  12. Gourdji D., Bataille D., Vauclin N., Grouselle D., Rosselin G., Tixier-Vidal A. Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release. FEBS Lett. 1979 Aug 1;104(1):165–168. doi: 10.1016/0014-5793(79)81107-2. [DOI] [PubMed] [Google Scholar]
  13. Granner D. K. The role of glucocorticoid hormones as biological amplifiers. Monogr Endocrinol. 1979;12:593–611. doi: 10.1007/978-3-642-81265-1_33. [DOI] [PubMed] [Google Scholar]
  14. Harms P. G., Langlier P., McCann S. M. Modification of stress-induced prolactin release by dexamethasone or adrenalectomy. Endocrinology. 1975 Feb;96(2):475–478. doi: 10.1210/endo-96-2-475. [DOI] [PubMed] [Google Scholar]
  15. Hymer W. C., Evans W. H., Kraicer J., Mastro A., Davis J., Griswold E. Enrichment of cell types from the rat adenohypophysis by sedimentation at unit gravity. Endocrinology. 1973 Jan;92(1):275–287. doi: 10.1210/endo-92-1-275. [DOI] [PubMed] [Google Scholar]
  16. Kato Y., Iwasaki Y., Iwasaki J., Abe H., Yanaihara N., Imura H. Prolactin release by vasoactive intestinal polypeptide in rats. Endocrinology. 1978 Aug;103(2):554–558. doi: 10.1210/endo-103-2-554. [DOI] [PubMed] [Google Scholar]
  17. Koch B., Lutz-Bucher B., Briaud B., Mialhe C. Specific interaction of corticosteroids with binding sites in the plasma membranes of the rat anterior pituitary gland. J Endocrinol. 1978 Nov;79(2):215–222. doi: 10.1677/joe.0.0790215. [DOI] [PubMed] [Google Scholar]
  18. Koch B., Lutz B., Briaud B., Mialhe C. Heterogeneity of pituitary glucocorticoid binding evidence for a transcortin-like compound. Biochim Biophys Acta. 1976 Sep 24;444(2):497–507. doi: 10.1016/0304-4165(76)90393-7. [DOI] [PubMed] [Google Scholar]
  19. Krieger D. T., Howanitz P. J., Frantz A. G. Absence of nocturnal elevation of plasma prolactin concentrations in Cushing's disease. J Clin Endocrinol Metab. 1976 Feb;42(2):260–272. doi: 10.1210/jcem-42-2-260. [DOI] [PubMed] [Google Scholar]
  20. Lantigua R. A., Streck W. F., Lockwood D. H., Jacobs L. S. Glucocorticoid suppression of pancreatic and pituitary hormones: pancreatic polypeptide, growth hormone, and prolactin. J Clin Endocrinol Metab. 1980 Feb;50(2):298–303. doi: 10.1210/jcem-50-2-298. [DOI] [PubMed] [Google Scholar]
  21. Moguilewsky M., Raynaud J. P. Evidence for a specific mineralocorticoid receptor in rat pituitary and brain. J Steroid Biochem. 1980 Jan;12:309–314. doi: 10.1016/0022-4731(80)90285-x. [DOI] [PubMed] [Google Scholar]
  22. Pietras R. J., Szego C. M. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature. 1977 Jan 6;265(5589):69–72. doi: 10.1038/265069a0. [DOI] [PubMed] [Google Scholar]
  23. Raynaud J. P., Bouton M. M., Moguilewsky M., Ojasoo T., Philibert D., Beck G., Labrie F., Mornon J. P. Steroid hormone receptors and pharmacology. J Steroid Biochem. 1980 Jan;12:143–157. doi: 10.1016/0022-4731(80)90264-2. [DOI] [PubMed] [Google Scholar]
  24. Robberecht P., Deschodt-Lanckman M., Camus J. C., de Neef P., Lambert M., Christophe J. VIP activation of rat anterior pituitary adenylate cyclase. FEBS Lett. 1979 Jul 15;103(2):229–233. doi: 10.1016/0014-5793(79)81333-2. [DOI] [PubMed] [Google Scholar]
  25. Rotsztejn W. H., Benoist L., Besson J., Beraud G., Bluet-Pajot M. T., Kordon C., Rosselin G., Duval J. Effect of vasoactive intestinal peptide (VIP) on the release of adenohypophyseal hormones from purified cells obtained by unit gravity sedimentation. Inhibition by dexamethasone of vip-induced prolactin release. Neuroendocrinology. 1980 Oct;31(4):282–286. doi: 10.1159/000123089. [DOI] [PubMed] [Google Scholar]
  26. Rotsztejn W. H., Besson J., Briaud B., Gagnant L., Rosselin G., Kordon C. Effect of steroids on vasoactive intestinal peptide in discrete brain regions and peripheral tissues. Neuroendocrinology. 1980 Oct;31(4):287–291. doi: 10.1159/000123090. [DOI] [PubMed] [Google Scholar]
  27. Rotsztejn W. H., Normand M., Lalonde J., Fortier C. Relationship between ACTH release and corticosterone binding by the receptor sites of the adenohypophysis and dorsal hippocampus following infusion of corticosterone at a constant rate in the adrenalectomized rat. Endocrinology. 1975 Jul;97(1):223–230. doi: 10.1210/endo-97-1-223. [DOI] [PubMed] [Google Scholar]
  28. Ruberg M., Rotsztejn W. H., Arancibia S., Besson J., Enjalbert A. Stimulation of prolactin release by vasoactive intestinal peptide (VIP). Eur J Pharmacol. 1978 Oct 1;51(3):319–320. doi: 10.1016/0014-2999(78)90421-1. [DOI] [PubMed] [Google Scholar]
  29. Said S. I., Porter J. C. Vasoactive intestinal polypeptide: release into hypophyseal portal blood. Life Sci. 1979 Jan 15;24(3):227–230. doi: 10.1016/0024-3205(79)90223-6. [DOI] [PubMed] [Google Scholar]
  30. Shaar C. J., Clemens J. A., Dininger N. B. Effect of vasoactive intestinal polypeptide on prolactin release in vitro. Life Sci. 1979 Dec 10;25(24-25):2071–2074. doi: 10.1016/0024-3205(79)90199-1. [DOI] [PubMed] [Google Scholar]
  31. Sheppard H., Wiggan G., Tsien W. H. Structure-activity relationships for inhibitors of phosphodiesterase from erythrocytes and other tissues. Adv Cyclic Nucleotide Res. 1972;1:103–112. [PubMed] [Google Scholar]
  32. Shimatsu A., Kato Y., Matsushita N., Katakami H., Yanaihara N., Imura H. Immunoreactive vasoactive intestinal polypeptide in rat hypophysial portal blood. Endocrinology. 1981 Feb;108(2):395–398. doi: 10.1210/endo-108-2-395. [DOI] [PubMed] [Google Scholar]
  33. Sowers J. R., Carlson H. E., Brautbar N., Hershman J. M. Effect of dexamethasone on prolactin and TSH responses to TRH and metoclopramide in man. J Clin Endocrinol Metab. 1977 Feb;44(2):237–241. doi: 10.1210/jcem-44-2-237. [DOI] [PubMed] [Google Scholar]
  34. Steiner A. L., Parker C. W., Kipnis D. M. Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem. 1972 Feb 25;247(4):1106–1113. [PubMed] [Google Scholar]
  35. Suyemitsu T., Terayama H. Specific binding sites for natural glucocorticoids in plasma membranes of rat liver. Endocrinology. 1975 Jun;96(6):1499–1508. doi: 10.1210/endo-96-6-1499. [DOI] [PubMed] [Google Scholar]
  36. Vale W., River C. Substances modulating the secretion of ACTH by cultured anterior pituitary cells. Fed Proc. 1977 Jul;36(8):2094–2099. [PubMed] [Google Scholar]
  37. Vijayan E., Samson W. K., Said S. I., McCann S. M. Vasoactive intestinal peptide: evidence for a hypothalamic site of action to release growth hormone, luteinizing hormone, and prolactin in conscious ovariectomized rats. Endocrinology. 1979 Jan;104(1):53–57. doi: 10.1210/endo-104-1-53. [DOI] [PubMed] [Google Scholar]
  38. YALOW R. S., BERSON S. A. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960 Jul;39:1157–1175. doi: 10.1172/JCI104130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. de Kloet E. R., Burbach P., Mulder G. H. Localization and role of transcortin-like molecules in the anterior pituitary. Mol Cell Endocrinol. 1977 May;7(3):261–273. doi: 10.1016/0303-7207(77)90058-2. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES